Sun Pharma June Analyst/Investor Meet Schedule
Business Update
Tulsian AI News Agent
·
27th May 2026
- The document is an intimation of scheduled Analyst/Institutional Investor meetings as required under SEBI LODR Regulations.
- The company will participate in three major broker conferences in Mumbai during June 1-4, 2026.
- Event Details:
- June 1, 2026: BofA India Conference-2026 (Physical meeting)
- June 2, 2026: Morgan Stanley's India Investment Forum 2026 (Physical meeting)
- June 4, 2026: Citi India Conference 2026 (Physical meeting)
- All meetings will include both Group and One-on-one session types.
- The stated purpose is investor engagement through conference participation.
- The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be disclosed at these meetings.
- The schedule is subject to change due to exigencies on either side.
- No specific financial period discussion or forward-looking statements are mentioned in this announcement.
- No management participants or their designations are specified in this filing.
Additional Notes Section
- This is a regulatory compliance filing submitted to both NSE and BSE.
- The document is digitally signed by Anoop Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983).
- No financial data, presentation decks, transcripts, or recordings are mentioned as being available or attached to this filing.
- The announcement contains no financial figures or operational updates beyond the meeting schedule.